Adverse events in haematological malignancies

FromThe Lancet Haematology in conversation with

Start listening View podcast show

Adverse events in haematological malignancies

FromThe Lancet Haematology in conversation with

ratings:

Length:

13 minutes

Released:

Jun 12, 2018

Format:

Podcast episode

Description

Lead author Gita Thanarajasingam joins The Lancet Haematology to discuss the new Commission on assessment and adverse event reporting in haematological malignancies.

Released:

Jun 12, 2018

Format:

Podcast episode

Titles in the series (43)

Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Haematology: December 1, 2014 by The Lancet Haematology in conversation with
11 min listen
The Lancet Haematology: January 7, 2015 by The Lancet Haematology in conversation with
10 min listen
1 million stem cells: The Lancet Haematology: February 27, 2015 by The Lancet Haematology in conversation with
13 min listen
Deep-vein thrombosis: The Lancet Haematology, October 29, 2015 by The Lancet Haematology in conversation with
8 min listen
INWORKS: The Lancet Haematology: June 29, 2015 by The Lancet Haematology in conversation with
7 min listen
Warfarin: The Lancet Haematology: May 26, 2015 by The Lancet Haematology in conversation with
12 min listen
Trauma-induced coagulopathy: The Lancet Haematology: June issue by The Lancet Haematology in conversation with
9 min listen
Castleman disease: The Lancet Haematology: March 17, 2016 by The Lancet Haematology in conversation with
17 min listen
Atrial fibrillation and NOACs: The Lancet Haematology: April 2, 2015 by The Lancet Haematology in conversation with
9 min listen
Financial toxicity: The Lancet Haematology: September 17, 2015 by The Lancet Haematology in conversation with
6 min listen
Idiopathic thrombocytopenic purpura: The Lancet Haematology: July 29, 2015 by The Lancet Haematology in conversation with
6 min listen
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017 by The Lancet Haematology in conversation with
6 min listen
Economic burden of blood disorders in Europe: The Lancet Haematology: July 21, 2016 by The Lancet Haematology in conversation with
10 min listen
Imatinib for paediatric leukaemia by The Lancet Haematology in conversation with
9 min listen
Adverse events in haematological malignancies by The Lancet Haematology in conversation with
13 min listen
Superficial-vein thrombosis: The Lancet Haematology: February 15 2017 by The Lancet Haematology in conversation with
10 min listen
Nada Hamad on inclusion and diversity in haematology by The Lancet Haematology in conversation with
30 min listen
Eugenia Trigoso Arjona (in English) on nursing and haematological care by The Lancet Haematology in conversation with
29 min listen
Dr Judith Boer on lymphoblastic leukaemia in children by The Lancet Haematology in conversation with
10 min listen
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017 by The Lancet Haematology in conversation with
9 min listen
Predicting the risk of adenoviraemia by The Lancet Haematology in conversation with
5 min listen
Raul Cordoba on haematological malignancies in older people by The Lancet Haematology in conversation with
16 min listen
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care by The Lancet Haematology in conversation with
29 min listen
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma by The Lancet Haematology in conversation with
17 min listen
Zuguo Mei and Gary Brittenham on iron deficiency by The Lancet Haematology in conversation with
9 min listen
Fredrik Schjesvold on OCEAN phase 3 by The Lancet Haematology in conversation with
12 min listen
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia by The Lancet Haematology in conversation with
12 min listen
Xiao-Jun Huang on cellular therapy in China by The Lancet Haematology in conversation with
28 min listen
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders by The Lancet Haematology in conversation with
13 min listen
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline by The Lancet Haematology in conversation with
15 min listen

More Episodes from The Lancet Haematology in conversation with

Skip carousel

Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia by The Lancet Haematology in conversation with
18 min listen
Elisabeth Schorb on the MARTA phase 2 trial by The Lancet Haematology in conversation with
9 min listen
Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies by The Lancet Haematology in conversation with
13 min listen
Dr Susan O'Brien on the PREVAPIX-ALL trial by The Lancet Haematology in conversation with
14 min listen
Enrico Lopriore on haemolytic disease of the fetus and newborn by The Lancet Haematology in conversation with
13 min listen
Meletios Dimopoulos on relapsed and refractory multiple myeloma by The Lancet Haematology in conversation with
11 min listen
$Meletios Dimopoulos on relapsed and refractory multiple myeloma$
Eric Ohuma on haemoglobin concentrations and neonatal outcomes by The Lancet Haematology in conversation with
16 min listen
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding by The Lancet Haematology in conversation with
13 min listen
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma by The Lancet Haematology in conversation with
17 min listen
Alok Srivastava on fitusiran for patients with haemophilia A and B by The Lancet Haematology in conversation with
19 min listen
Emmanuela E Ambrose on stroke prevention in children with sickle cell disease by The Lancet Haematology in conversation with
12 min listen
Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes by The Lancet Haematology in conversation with
22 min listen
Xiao-Jun Huang on cellular therapy in China by The Lancet Haematology in conversation with
28 min listen
Glenn Pierce on haemophilia care in LMICs by The Lancet Haematology in conversation with
35 min listen
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders by The Lancet Haematology in conversation with
13 min listen
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline by The Lancet Haematology in conversation with
15 min listen
Fredrik Schjesvold on OCEAN phase 3 by The Lancet Haematology in conversation with
12 min listen
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia by The Lancet Haematology in conversation with
12 min listen
Raul Cordoba on haematological malignancies in older people by The Lancet Haematology in conversation with
16 min listen
Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria by The Lancet Haematology in conversation with
9 min listen
Zuguo Mei and Gary Brittenham on iron deficiency by The Lancet Haematology in conversation with
9 min listen
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care by The Lancet Haematology in conversation with
29 min listen
Eugenia Trigoso Arjona (in English) on nursing and haematological care by The Lancet Haematology in conversation with
29 min listen
Nada Hamad on inclusion and diversity in haematology by The Lancet Haematology in conversation with
30 min listen
Dr Judith Boer on lymphoblastic leukaemia in children by The Lancet Haematology in conversation with
10 min listen
Imatinib for paediatric leukaemia by The Lancet Haematology in conversation with
9 min listen
Predicting the risk of adenoviraemia by The Lancet Haematology in conversation with
5 min listen
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017 by The Lancet Haematology in conversation with
9 min listen
Trauma-induced coagulopathy: The Lancet Haematology: June issue by The Lancet Haematology in conversation with
9 min listen
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017 by The Lancet Haematology in conversation with
6 min listen

Discover this podcast and so much more

Adverse events in haematological malignancies

Adverse events in haematological malignancies

Description

Titles in the series (43)

More Episodes from The Lancet Haematology in conversation with